# Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)

> **NCT03781791** · PHASE2 · COMPLETED · sponsor: **Enterin Inc.** · enrollment: 151 (actual)

## Conditions studied

- Constipation
- Parkinson Disease

## Interventions

- **DRUG:** Active Investigational Treatment ENT-01
- **DRUG:** Placebo Treatment

## Key facts

- **NCT ID:** NCT03781791
- **Lead sponsor:** Enterin Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-12-10
- **Primary completion:** 2021-12-14
- **Final completion:** 2021-12-14
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03781791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03781791, "Orally Administered ENT-01 for Parkinson's Disease-Related Constipation (KARMET)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03781791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*